Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring (Jan 2018)

Temporospatial components of brain ERPs as biomarkers for Alzheimer's disease

  • Robert M. Chapman,
  • Margaret N. Gardner,
  • Rafael Klorman,
  • Mark Mapstone,
  • Anton P. Porsteinsson,
  • Inga M. Antonsdottir,
  • Lily Kamalyan

DOI
https://doi.org/10.1016/j.dadm.2018.08.002
Journal volume & issue
Vol. 10, no. 1
pp. 604 – 614

Abstract

Read online

Abstract Introduction Developing biomarkers that distinguish individuals with Alzheimer's disease (AD) from those with normal cognition remains a crucial goal for improving the health of older adults. We investigated adding brain spatial information to temporal event‐related potentials (ERPs) to increase AD identification accuracy over temporal ERPs alone. Methods With two‐step principal components analysis, we applied multivariate analyses that incorporated temporal and spatial ERP information from a cognitive task. Discriminant analysis used temporospatial ERP scores to classify participants as belonging to either the AD or healthy control group. Results Temporospatial ERPs produced a cross‐validated area under the curve of 0.84. Adding spatial information through a formal procedure significantly improves classification accuracy. Discussion A weighted combination of temporospatial ERP markers performs well in detecting AD. Because ERPs are noninvasive and inexpensive, they may be promising biomarkers for AD that can add functional information to other biomarker systems while providing the individual's probability of correct classification.

Keywords